Igfbp1 | Mouse | (+)-schisandrin B | multiple interactions | ISO | RGD:2872 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] | CTD | PMID:31150632 |
Igfbp1 | Mouse | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:2872 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of IGFBP1 mRNA] | CTD | PMID:19414516 |
Igfbp1 | Mouse | 1,1-dichloroethene | decreases expression | EXP | | 6480464 | vinylidene chloride results in decreased expression of IGFBP1 mRNA | CTD | PMID:26682919 |
Igfbp1 | Mouse | 1-methylphenanthrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
Igfbp1 | Mouse | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2872 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070|PMID:18289764|PMID:25380136 |
Igfbp1 | Mouse | 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:69038 | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP1 mRNA | CTD | PMID:27344345 |
Igfbp1 | Mouse | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA | CTD | PMID:15913567 |
Igfbp1 | Mouse | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:14976129 |
Igfbp1 | Mouse | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP1 mRNA | CTD | PMID:17942748 |
Igfbp1 | Mouse | 17alpha-ethynylestradiol | increases expression | ISO | RGD:2872 | 6480464 | Ethinyl Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:15795090 |
Igfbp1 | Mouse | 17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | [Cyclic AMP co-treated with Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA; more ... | CTD | PMID:11756571|PMID:12093828|PMID:17404688|PMID:17484513|PMID:20085912|PMID:20823114|PMID:31154070|PMID:31646340|PMID:32446389 |
Igfbp1 | Mouse | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:39298647 |
Igfbp1 | Mouse | 17beta-estradiol | affects expression | ISO | RGD:2872 | 6480464 | Estradiol affects the expression of IGFBP1 mRNA | CTD | PMID:32145629 |
Igfbp1 | Mouse | 17beta-estradiol | decreases expression | ISO | RGD:69038 | 6480464 | Estradiol results in decreased expression of IGFBP1 mRNA | CTD | PMID:31646340 |
Igfbp1 | Mouse | 17beta-estradiol | increases expression | ISO | RGD:69038 | 6480464 | Estradiol results in increased expression of IGFBP1 mRNA; Estradiol results in increased expression of IGFBP1 more ... | CTD | PMID:12154049|PMID:17484513|PMID:31614463 |
Igfbp1 | Mouse | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:69038 | 6480464 | Dihydrotestosterone results in increased expression of IGFBP1 mRNA | CTD | PMID:29581250 |
Igfbp1 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:2872 | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGFBP1 mRNA | CTD | PMID:27291303 |
Igfbp1 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of IGFBP1 mRNA | CTD | PMID:30294300 |
Igfbp1 | Mouse | 2,2'-bipyridine | increases expression | ISO | RGD:69038 | 6480464 | 2,2'-Dipyridyl results in increased expression of IGFBP1 mRNA | CTD | PMID:19924283 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA]; [Tetrachlorodibenzodioxin co-treated with more ... | CTD | PMID:17942748|PMID:18827440|PMID:19782052|PMID:25975270|PMID:28213091 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA | CTD | PMID:28922406 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA; Tetrachlorodibenzodioxin results in increased expression of IGFBP1 more ... | CTD | PMID:15056799|PMID:15496506|PMID:16697128|PMID:20106945|PMID:21632981|PMID:26159488|PMID:26238291 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA | CTD | PMID:16054898|PMID:16960034|PMID:18178546|PMID:19692669|PMID:20959002|PMID:21215274|PMID:32109520|PMID:34747641 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2872 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA | CTD | PMID:22298810 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:2872 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] | CTD | PMID:21215274 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA; Tetrachlorodibenzodioxin results in increased expression of IGFBP1 more ... | CTD | PMID:16960034|PMID:18827440|PMID:19782052|PMID:28213091 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69038 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA | CTD | PMID:22298810 |
Igfbp1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IGFBP1 mRNA | CTD | PMID:17949056 |
Igfbp1 | Mouse | 2,4-dinitrotoluene | affects expression | ISO | RGD:2872 | 6480464 | 2,4-dinitrotoluene affects the expression of IGFBP1 mRNA | CTD | PMID:21346803 |
Igfbp1 | Mouse | 2-amino-2-deoxy-D-galactopyranose | increases expression | ISO | RGD:2872 | 6480464 | Galactosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:11779202 |
Igfbp1 | Mouse | 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of IGFBP1 mRNA | CTD | PMID:19812364 |
Igfbp1 | Mouse | 2-hydroxy-17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | 2-hydroxy-17beta-estradiol | increases expression | ISO | RGD:69038 | 6480464 | 2-hydroxyestradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | 2-nitrofluorene | increases expression | ISO | RGD:2872 | 6480464 | 2-nitrofluorene results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
Igfbp1 | Mouse | 28-Homobrassinolide | increases expression | ISO | RGD:2872 | 6480464 | homobrassinolide results in increased expression of IGFBP1 mRNA | CTD | PMID:21491949 |
Igfbp1 | Mouse | 3',5'-cyclic AMP | multiple interactions | ISO | RGD:69038 | 6480464 | 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:31953017|PMID:32446389|PMID:32781018 |
Igfbp1 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:2872 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGFBP1 mRNA | CTD | PMID:19692669|PMID:20959002 |
Igfbp1 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | affects expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of IGFBP1 mRNA | CTD | PMID:37080397 |
Igfbp1 | Mouse | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol | affects expression | ISO | RGD:2872 | 6480464 | fluorotelomer alcohols affects the expression of IGFBP1 mRNA | CTD | PMID:38903859 |
Igfbp1 | Mouse | 3-chloropropane-1,2-diol | multiple interactions | EXP | | 6480464 | [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA | CTD | PMID:33187795 |
Igfbp1 | Mouse | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2872 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
Igfbp1 | Mouse | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:2872 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764|PMID:25380136 |
Igfbp1 | Mouse | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of IGFBP1 mRNA | CTD | PMID:30951980 |
Igfbp1 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:69038 | 6480464 | bisphenol S results in decreased methylation of IGFBP1 gene | CTD | PMID:31601247 |
Igfbp1 | Mouse | 4,4'-sulfonyldiphenol | affects expression | EXP | | 6480464 | bisphenol S affects the expression of IGFBP1 mRNA | CTD | PMID:39298647 |
Igfbp1 | Mouse | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:2872 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
Igfbp1 | Mouse | 4-hydroxy-17beta-estradiol | multiple interactions | ISO | RGD:69038 | 6480464 | 4-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | 4-hydroxy-17beta-estradiol | increases expression | ISO | RGD:69038 | 6480464 | 4-hydroxyestradiol results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of IGFBP1 mRNA | CTD | PMID:28973697 |
Igfbp1 | Mouse | 5-azacytidine | increases expression | ISO | RGD:69038 | 6480464 | Azacitidine results in increased expression of IGFBP1 mRNA | CTD | PMID:20823114 |
Igfbp1 | Mouse | 5-azacytidine | multiple interactions | ISO | RGD:69038 | 6480464 | Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased more ... | CTD | PMID:20823114 |
Igfbp1 | Mouse | 8-Br-cAMP | increases secretion | ISO | RGD:69038 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein | CTD | PMID:21273127 |
Igfbp1 | Mouse | 8-Br-cAMP | increases expression | ISO | RGD:69038 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate more ... | CTD | PMID:17065600|PMID:20147733|PMID:23275455 |
Igfbp1 | Mouse | 8-Br-cAMP | decreases expression | ISO | RGD:69038 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate more ... | CTD | PMID:18815356 |
Igfbp1 | Mouse | 8-Br-cAMP | multiple interactions | ISO | RGD:69038 | 6480464 | 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; more ... | CTD | PMID:16709600|PMID:17065600|PMID:21903722|PMID:23275455 |
Igfbp1 | Mouse | afimoxifene | increases expression | ISO | RGD:69038 | 6480464 | afimoxifene results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
Igfbp1 | Mouse | aflatoxin B1 | increases expression | ISO | RGD:2872 | 6480464 | Aflatoxin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375|PMID:25378103 |
Igfbp1 | Mouse | aflatoxin B1 | decreases methylation | ISO | RGD:69038 | 6480464 | Aflatoxin B1 results in decreased methylation of IGFBP1 gene | CTD | PMID:27153756 |
Igfbp1 | Mouse | aflatoxin B1 | increases expression | ISO | RGD:69038 | 6480464 | Aflatoxin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:21632981|PMID:21641981|PMID:32234424 |
Igfbp1 | Mouse | aflatoxin B1 | affects expression | ISO | RGD:69038 | 6480464 | Aflatoxin B1 affects the expression of IGFBP1 protein | CTD | PMID:20106945 |
Igfbp1 | Mouse | amiodarone | increases expression | ISO | RGD:69038 | 6480464 | Amiodarone results in increased expression of IGFBP1 mRNA | CTD | PMID:27089845 |
Igfbp1 | Mouse | ammonium chloride | affects expression | ISO | RGD:2872 | 6480464 | Ammonium Chloride affects the expression of IGFBP1 mRNA | CTD | PMID:16483693 |
Igfbp1 | Mouse | amphetamine | increases expression | ISO | RGD:2872 | 6480464 | Amphetamine results in increased expression of IGFBP1 mRNA | CTD | PMID:15183010 |
Igfbp1 | Mouse | Archazolid B | increases expression | ISO | RGD:69038 | 6480464 | archazolid B results in increased expression of IGFBP1 mRNA | CTD | PMID:25218289 |
Igfbp1 | Mouse | aristolochic acids | increases expression | ISO | RGD:2872 | 6480464 | Aristolochic Acids results in increased expression of IGFBP1 mRNA | CTD | PMID:19717638 |
Igfbp1 | Mouse | Aroclor 1254 | increases expression | ISO | RGD:2872 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of IGFBP1 mRNA | CTD | PMID:18178546 |
Igfbp1 | Mouse | arsenite(3-) | multiple interactions | ISO | RGD:69038 | 6480464 | Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA] | CTD | PMID:31646340 |
Igfbp1 | Mouse | arsenite(3-) | decreases expression | ISO | RGD:69038 | 6480464 | arsenite results in decreased expression of IGFBP1 mRNA | CTD | PMID:31646340 |
Igfbp1 | Mouse | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of IGFBP1 mRNA | CTD | PMID:15073043 |
Igfbp1 | Mouse | arsenous acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein | CTD | PMID:27430728 |
Igfbp1 | Mouse | atazanavir sulfate | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | azoxystrobin | multiple interactions | ISO | RGD:2872 | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 |
Igfbp1 | Mouse | azoxystrobin | increases expression | ISO | RGD:69038 | 6480464 | azoxystrobin results in increased expression of IGFBP1 mRNA | CTD | PMID:39207506 |
Igfbp1 | Mouse | bacitracin | increases expression | ISO | RGD:2872 | 6480464 | Bacitracin results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
Igfbp1 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of IGFBP1 mRNA | CTD | PMID:19770486|PMID:39454710 |
Igfbp1 | Mouse | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | CXCL12 protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of IGFBP1 mRNA] | CTD | PMID:39454710 |
Igfbp1 | Mouse | benzo[a]pyrene | increases methylation | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased methylation of IGFBP1 exon; Benzo(a)pyrene results in increased methylation of IGFBP1 more ... | CTD | PMID:27901495 |
Igfbp1 | Mouse | benzo[a]pyrene | increases expression | ISO | RGD:69038 | 6480464 | Benzo(a)pyrene results in increased expression of IGFBP1 mRNA; Benzo(a)pyrene results in increased expression of IGFBP1 more ... | CTD | PMID:16269432|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424|PMID:33278487 |
Igfbp1 | Mouse | benzo[a]pyrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA; [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects more ... | CTD | PMID:17690111 |
Igfbp1 | Mouse | benzo[a]pyrene diol epoxide I | increases expression | ISO | RGD:69038 | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IGFBP1 mRNA | CTD | PMID:26238291 |
Igfbp1 | Mouse | benzo[b]fluoranthene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
Igfbp1 | Mouse | benzo[b]fluoranthene | increases expression | ISO | RGD:69038 | 6480464 | benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
Igfbp1 | Mouse | Benzo[b]fluorene | affects expression | ISO | RGD:2872 | 6480464 | benzo(b)fluorene affects the expression of IGFBP1 mRNA | CTD | PMID:38903859 |
Igfbp1 | Mouse | beta-lapachone | increases expression | ISO | RGD:69038 | 6480464 | beta-lapachone results in increased expression of IGFBP1 mRNA | CTD | PMID:38218311 |
Igfbp1 | Mouse | beta-naphthoflavone | increases expression | ISO | RGD:69038 | 6480464 | beta-Naphthoflavone results in increased expression of IGFBP1 mRNA | CTD | PMID:19737606 |
Igfbp1 | Mouse | bexarotene | increases expression | ISO | RGD:2872 | 6480464 | bexarotene results in increased expression of IGFBP1 mRNA | CTD | PMID:16648578 |
Igfbp1 | Mouse | bicalutamide | multiple interactions | ISO | RGD:69038 | 6480464 | [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein | CTD | PMID:16847815 |
Igfbp1 | Mouse | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA | CTD | PMID:19850644 |
Igfbp1 | Mouse | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA] | CTD | PMID:19850644 |
Igfbp1 | Mouse | bisphenol A | increases secretion | ISO | RGD:69038 | 6480464 | bisphenol A results in increased secretion of IGFBP1 protein | CTD | PMID:26604029 |
Igfbp1 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of IGFBP1 mRNA | CTD | PMID:30245210 |
Igfbp1 | Mouse | bisphenol A | increases expression | ISO | RGD:2872 | 6480464 | bisphenol A results in increased expression of IGFBP1 mRNA | CTD | PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998 |
Igfbp1 | Mouse | bisphenol A | affects expression | ISO | RGD:2872 | 6480464 | bisphenol A affects the expression of IGFBP1 mRNA | CTD | PMID:30903817 |
Igfbp1 | Mouse | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of IGFBP1 mRNA | CTD | PMID:30951980 |
Igfbp1 | Mouse | bisphenol A | affects expression | ISO | RGD:69038 | 6480464 | bisphenol A affects the expression of IGFBP1 mRNA | CTD | PMID:30903817 |
Igfbp1 | Mouse | bisphenol A | increases expression | ISO | RGD:69038 | 6480464 | bisphenol A results in increased expression of IGFBP1 mRNA; bisphenol A results in increased expression more ... | CTD | PMID:21273127|PMID:26604029|PMID:27979917 |
Igfbp1 | Mouse | bisphenol A | multiple interactions | ISO | RGD:69038 | 6480464 | [Progesterone co-treated with bisphenol A] results in increased expression of IGFBP1 mRNA | CTD | PMID:26604029 |
Igfbp1 | Mouse | bisphenol F | decreases expression | EXP | | 6480464 | bisphenol F results in decreased expression of IGFBP1 mRNA | CTD | PMID:30951980 |
Igfbp1 | Mouse | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of IGFBP1 mRNA | CTD | PMID:38685157 |
Igfbp1 | Mouse | bucladesine | increases expression | ISO | RGD:69038 | 6480464 | Bucladesine results in increased expression of IGFBP1 | CTD | PMID:12093828 |
Igfbp1 | Mouse | bucladesine | multiple interactions | ISO | RGD:69038 | 6480464 | [Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Estradiol co-treated with more ... | CTD | PMID:20823114|PMID:30328349 |
Igfbp1 | Mouse | butan-1-ol | multiple interactions | ISO | RGD:69038 | 6480464 | 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] | CTD | PMID:17065600 |
Igfbp1 | Mouse | butanal | decreases expression | ISO | RGD:69038 | 6480464 | butyraldehyde results in decreased expression of IGFBP1 mRNA | CTD | PMID:26079696 |
Igfbp1 | Mouse | Butylbenzyl phthalate | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | C60 fullerene | decreases expression | ISO | RGD:2872 | 6480464 | fullerene C60 results in decreased expression of IGFBP1 mRNA | CTD | PMID:19167457 |
Igfbp1 | Mouse | cadmium atom | multiple interactions | ISO | RGD:69038 | 6480464 | Fulvestrant inhibits the reaction [Cadmium results in decreased expression of IGFBP1 mRNA] | CTD | PMID:31646340 |
Igfbp1 | Mouse | cadmium atom | decreases expression | ISO | RGD:69038 | 6480464 | Cadmium results in decreased expression of IGFBP1 mRNA | CTD | PMID:31646340 |
Igfbp1 | Mouse | cadmium dichloride | increases expression | ISO | RGD:69038 | 6480464 | Cadmium Chloride results in increased expression of IGFBP1 protein | CTD | PMID:26138014 |
Igfbp1 | Mouse | cadmium dichloride | multiple interactions | ISO | RGD:69038 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] | CTD | PMID:26138014 |
Igfbp1 | Mouse | cadmium dichloride | increases expression | ISO | RGD:2872 | 6480464 | Cadmium Chloride results in increased expression of IGFBP1 mRNA | CTD | PMID:25993096 |
Igfbp1 | Mouse | caffeine | increases expression | ISO | RGD:69038 | 6480464 | Caffeine results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227 |
Igfbp1 | Mouse | calcitriol | increases expression | ISO | RGD:69038 | 6480464 | Calcitriol results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
Igfbp1 | Mouse | calcitriol | multiple interactions | ISO | RGD:69038 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
Igfbp1 | Mouse | cannabidiol | multiple interactions | ISO | RGD:69038 | 6480464 | Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:31953017 |
Igfbp1 | Mouse | carbamazepine | affects expression | ISO | RGD:69038 | 6480464 | Carbamazepine affects the expression of IGFBP1 mRNA | CTD | PMID:24752500 |
Igfbp1 | Mouse | chenodeoxycholic acid | decreases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in decreased expression of IGFBP1 mRNA | CTD | PMID:19072826 |
Igfbp1 | Mouse | chenodeoxycholic acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | chlorpromazine | increases expression | ISO | RGD:69038 | 6480464 | Chlorpromazine results in increased expression of IGFBP1 mRNA | CTD | PMID:15924885 |
Igfbp1 | Mouse | chlorpyrifos | multiple interactions | ISO | RGD:2872 | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 |
Igfbp1 | Mouse | cholesterol | multiple interactions | EXP | | 6480464 | [Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IGFBP1 mRNA | CTD | PMID:22129739 |
Igfbp1 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 |
Igfbp1 | Mouse | chromium(3+) trichloride | decreases expression | EXP | | 6480464 | chromic chloride results in decreased expression of IGFBP1 mRNA | CTD | PMID:12153762 |
Igfbp1 | Mouse | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of IGFBP1 mRNA | CTD | PMID:18353800 |
Igfbp1 | Mouse | ciprofibrate | increases expression | EXP | | 6480464 | ciprofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:12771043 |
Igfbp1 | Mouse | cisplatin | affects expression | ISO | RGD:2872 | 6480464 | Cisplatin affects the expression of IGFBP1 mRNA | CTD | PMID:18289764 |
Igfbp1 | Mouse | cisplatin | multiple interactions | ISO | RGD:69038 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of IGFBP1 mRNA | CTD | PMID:27392435 |
Igfbp1 | Mouse | clofibrate | increases expression | ISO | RGD:2872 | 6480464 | Clofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
Igfbp1 | Mouse | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of IGFBP1 mRNA | CTD | PMID:17585979|PMID:23811191 |
Igfbp1 | Mouse | clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 |
Igfbp1 | Mouse | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of IGFBP1 mRNA | CTD | PMID:11356909 |
Igfbp1 | Mouse | clotrimazole | increases expression | ISO | RGD:69038 | 6480464 | Clotrimazole results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
Igfbp1 | Mouse | clotrimazole | increases secretion | ISO | RGD:69038 | 6480464 | Clotrimazole results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
Igfbp1 | Mouse | clozapine | increases expression | ISO | RGD:69038 | 6480464 | Clozapine results in increased expression of IGFBP1 protein | CTD | PMID:36482696 |
Igfbp1 | Mouse | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of IGFBP1 mRNA; cobaltous chloride results in increased expression more ... | CTD | PMID:16990490 |
Igfbp1 | Mouse | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of IGFBP1 mRNA | CTD | PMID:21139344 |
Igfbp1 | Mouse | colforsin daropate hydrochloride | increases expression | ISO | RGD:69038 | 6480464 | Colforsin results in increased expression of IGFBP1 | CTD | PMID:12093828 |
Igfbp1 | Mouse | colforsin daropate hydrochloride | multiple interactions | ISO | RGD:69038 | 6480464 | [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of IGFBP1 mRNA | CTD | PMID:31154070 |
Igfbp1 | Mouse | copper(II) sulfate | increases expression | ISO | RGD:69038 | 6480464 | Copper Sulfate results in increased expression of IGFBP1 mRNA | CTD | PMID:19549813 |
Igfbp1 | Mouse | corn oil | affects expression | ISO | RGD:2872 | 6480464 | Corn Oil affects the expression of IGFBP1 mRNA | CTD | PMID:16360708 |
Igfbp1 | Mouse | cortisol | multiple interactions | ISO | RGD:69038 | 6480464 | Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased more ... | CTD | PMID:23275455 |
Igfbp1 | Mouse | curcumin | multiple interactions | ISO | RGD:69038 | 6480464 | [arsenic trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein | CTD | PMID:27430728 |
Igfbp1 | Mouse | cyanamide | multiple interactions | ISO | RGD:2872 | 6480464 | Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] | CTD | PMID:12394292 |
Igfbp1 | Mouse | cyclosporin A | decreases expression | ISO | RGD:2872 | 6480464 | Cyclosporine results in decreased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
Igfbp1 | Mouse | cyclosporin A | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | cyclosporin A | increases expression | ISO | RGD:69038 | 6480464 | Cyclosporine results in increased expression of IGFBP1 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:27089845|PMID:27989131|PMID:34681664 |
Igfbp1 | Mouse | cyclosporin A | increases expression | ISO | RGD:2872 | 6480464 | Cyclosporine results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
Igfbp1 | Mouse | cypermethrin | decreases expression | EXP | | 6480464 | cypermethrin results in decreased expression of IGFBP1 mRNA; cypermethrin results in decreased expression of IGFBP1 more ... | CTD | PMID:36116546 |
Igfbp1 | Mouse | cyproconazole | increases expression | ISO | RGD:69038 | 6480464 | cyproconazole results in increased expression of IGFBP1 mRNA | CTD | PMID:39207506 |
Igfbp1 | Mouse | deoxycholic acid | decreases expression | ISO | RGD:69038 | 6480464 | Deoxycholic Acid results in decreased expression of IGFBP1 mRNA | CTD | PMID:27089845 |
Igfbp1 | Mouse | deoxycholic acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | dexamethasone | multiple interactions | ISO | RGD:69038 | 6480464 | [Dexamethasone results in increased phosphorylation of and results in increased activity of NR3C1 protein] which more ... | CTD | PMID:18483179|PMID:23275455 |
Igfbp1 | Mouse | dexamethasone | increases expression | ISO | RGD:2872 | 6480464 | Dexamethasone results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
Igfbp1 | Mouse | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of IGFBP1 mRNA | CTD | PMID:15073043 |
Igfbp1 | Mouse | diarsenic trioxide | multiple interactions | ISO | RGD:69038 | 6480464 | [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein | CTD | PMID:27430728 |
Igfbp1 | Mouse | dibenz[a,h]anthracene | increases expression | ISO | RGD:69038 | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
Igfbp1 | Mouse | dibenz[a,h]anthracene | decreases expression | EXP | | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of IGFBP1 mRNA | CTD | PMID:26377693 |
Igfbp1 | Mouse | dibenz[a,h]anthracene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
Igfbp1 | Mouse | dibenzo[a,l]pyrene | increases expression | ISO | RGD:69038 | 6480464 | dibenzo(a,l)pyrene results in increased expression of IGFBP1 mRNA | CTD | PMID:16269432 |
Igfbp1 | Mouse | dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:69038 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of IGFBP1 mRNA | CTD | PMID:17690111 |
Igfbp1 | Mouse | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of IGFBP1 mRNA | CTD | PMID:28962523 |
Igfbp1 | Mouse | diclofenac | affects expression | ISO | RGD:69038 | 6480464 | Diclofenac affects the expression of IGFBP1 mRNA | CTD | PMID:24752500 |
Igfbp1 | Mouse | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of IGFBP1 mRNA | CTD | PMID:26934552 |
Igfbp1 | Mouse | diethylstilbestrol | multiple interactions | EXP | | 6480464 | [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA | CTD | PMID:19665456 |
Igfbp1 | Mouse | diethylstilbestrol | increases expression | ISO | RGD:2872 | 6480464 | Diethylstilbestrol results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
Igfbp1 | Mouse | diisononyl phthalate | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15345372 |
Igfbp1 | Mouse | dioxygen | increases expression | ISO | RGD:69038 | 6480464 | Oxygen deficiency results in increased expression of IGFBP1 mRNA | CTD | PMID:19924283 |
Igfbp1 | Mouse | dorsomorphin | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [salvianolic acid A inhibits the reaction [Fatty Acids, Nonesterified results in more ... | CTD | PMID:39047806 |
Igfbp1 | Mouse | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of IGFBP1 protein | CTD | PMID:30517846 |
Igfbp1 | Mouse | doxorubicin | increases expression | ISO | RGD:69038 | 6480464 | Doxorubicin results in increased expression of IGFBP1 mRNA | CTD | PMID:29803840 |
Igfbp1 | Mouse | enalapril | increases expression | ISO | RGD:2872 | 6480464 | Enalapril results in increased expression of IGFBP1 mRNA | CTD | PMID:12883983 |
Igfbp1 | Mouse | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of IGFBP1 mRNA | CTD | PMID:35436446 |
Igfbp1 | Mouse | erythromycin estolate | increases expression | ISO | RGD:2872 | 6480464 | Erythromycin Estolate results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
Igfbp1 | Mouse | ethanol | multiple interactions | ISO | RGD:2872 | 6480464 | Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] | CTD | PMID:12394292 |
Igfbp1 | Mouse | ethanol | increases expression | ISO | RGD:2872 | 6480464 | Ethanol results in increased expression of IGFBP1 mRNA | CTD | PMID:12394292 |
Igfbp1 | Mouse | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of IGFBP1 mRNA | CTD | PMID:19167417 |
Igfbp1 | Mouse | fentin chloride | increases expression | ISO | RGD:2872 | 6480464 | triphenyltin chloride results in increased expression of IGFBP1 mRNA | CTD | PMID:37156404 |
Igfbp1 | Mouse | fluxapyroxad | increases expression | ISO | RGD:69038 | 6480464 | fluxapyroxad results in increased expression of IGFBP1 mRNA | CTD | PMID:39207506 |
Igfbp1 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 |
Igfbp1 | Mouse | fulvestrant | increases expression | ISO | RGD:69038 | 6480464 | Fulvestrant results in increased expression of IGFBP1 mRNA | CTD | PMID:31646340 |
Igfbp1 | Mouse | fulvestrant | multiple interactions | ISO | RGD:69038 | 6480464 | Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA]; Fulvestrant inhibits the more ... | CTD | PMID:31646340 |
Igfbp1 | Mouse | fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of IGFBP1 mRNA | CTD | PMID:16221962 |
Igfbp1 | Mouse | furan | increases expression | EXP | | 6480464 | furan results in increased expression of IGFBP1 mRNA | CTD | PMID:24183702|PMID:37517673 |
Igfbp1 | Mouse | furan | decreases expression | ISO | RGD:2872 | 6480464 | furan results in decreased expression of IGFBP1 mRNA | CTD | PMID:26194646 |
Igfbp1 | Mouse | genistein | decreases expression | ISO | RGD:2872 | 6480464 | Genistein results in decreased expression of IGFBP1 mRNA | CTD | PMID:17049845 |
Igfbp1 | Mouse | genistein | increases expression | ISO | RGD:2872 | 6480464 | Genistein results in increased expression of IGFBP1 mRNA | CTD | PMID:15795090 |
Igfbp1 | Mouse | gentamycin | increases expression | ISO | RGD:2872 | 6480464 | Gentamicins results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
Igfbp1 | Mouse | glycidol | multiple interactions | EXP | | 6480464 | [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA | CTD | PMID:33187795 |
Igfbp1 | Mouse | glycochenodeoxycholic acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | glycocholic acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | glycodeoxycholic acid | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | glyphosate | multiple interactions | ISO | RGD:2872 | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 |
Igfbp1 | Mouse | GW 4064 | increases expression | EXP | | 6480464 | GW 4064 results in increased expression of IGFBP1 mRNA | CTD | PMID:26655953 |
Igfbp1 | Mouse | hydrogen peroxide | multiple interactions | ISO | RGD:2872 | 6480464 | Hydrogen Peroxide inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
Igfbp1 | Mouse | imidacloprid | multiple interactions | ISO | RGD:2872 | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 |
Igfbp1 | Mouse | indirubin | increases expression | ISO | RGD:69038 | 6480464 | indirubin results in increased expression of IGFBP1 mRNA | CTD | PMID:15056799 |
Igfbp1 | Mouse | indole-3-methanol | multiple interactions | ISO | RGD:2872 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA; Acetylcysteine inhibits the reaction more ... | CTD | PMID:22129741 |
Igfbp1 | Mouse | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA | CTD | PMID:36331819 |
Igfbp1 | Mouse | ketamine | increases expression | ISO | RGD:2872 | 6480464 | Ketamine results in increased expression of IGFBP1 mRNA | CTD | PMID:20080153 |
Igfbp1 | Mouse | ketoconazole | increases expression | ISO | RGD:2872 | 6480464 | Ketoconazole results in increased expression of IGFBP1 mRNA | CTD | PMID:18289764 |
Igfbp1 | Mouse | kynurenine | increases expression | ISO | RGD:69038 | 6480464 | Kynurenine results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | kynurenine | multiple interactions | ISO | RGD:69038 | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 |
Igfbp1 | Mouse | L-tryptophan | increases expression | ISO | RGD:69038 | 6480464 | Tryptophan results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | L-tryptophan | multiple interactions | ISO | RGD:69038 | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of IGFBP1 mRNA | CTD | PMID:25270620 |
Igfbp1 | Mouse | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:21335049 |
Igfbp1 | Mouse | lead nitrate | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | leflunomide | increases expression | ISO | RGD:2872 | 6480464 | leflunomide results in increased expression of IGFBP1 mRNA | CTD | PMID:24136188 |
Igfbp1 | Mouse | leflunomide | increases expression | ISO | RGD:69038 | 6480464 | leflunomide results in increased expression of IGFBP1 mRNA | CTD | PMID:28988120 |
Igfbp1 | Mouse | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of IGFBP1 mRNA | CTD | PMID:27339419 |
Igfbp1 | Mouse | lipopolysaccharide | increases expression | ISO | RGD:2872 | 6480464 | Lipopolysaccharides results in increased expression of IGFBP1 mRNA | CTD | PMID:11779202 |
Igfbp1 | Mouse | lisinopril dihydrate | increases expression | ISO | RGD:69038 | 6480464 | Lisinopril results in increased expression of IGFBP1 protein | CTD | PMID:9663927 |
Igfbp1 | Mouse | medroxyprogesterone acetate | multiple interactions | ISO | RGD:69038 | 6480464 | 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:11756571|PMID:12093828|PMID:16709600|PMID:20823114|PMID:21903722|PMID:30328349|PMID:31154070|PMID:31953017|PMID:32781018 |
Igfbp1 | Mouse | medroxyprogesterone acetate | increases expression | ISO | RGD:69038 | 6480464 | Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA | CTD | PMID:11756571|PMID:20685861 |
Igfbp1 | Mouse | mercury atom | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | mercury dichloride | increases expression | ISO | RGD:2872 | 6480464 | Mercuric Chloride results in increased expression of IGFBP1 mRNA | CTD | PMID:7540432 |
Igfbp1 | Mouse | mercury(0) | multiple interactions | ISO | RGD:69038 | 6480464 | [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated more ... | CTD | PMID:32949613 |
Igfbp1 | Mouse | metformin | decreases expression | ISO | RGD:69038 | 6480464 | Metformin results in decreased expression of IGFBP1 mRNA | CTD | PMID:21316309 |
Igfbp1 | Mouse | metformin | decreases expression | ISO | RGD:2872 | 6480464 | Metformin results in decreased expression of IGFBP1 mRNA | CTD | PMID:31324951 |
Igfbp1 | Mouse | methapyrilene | increases expression | ISO | RGD:2872 | 6480464 | Methapyrilene results in increased expression of IGFBP1 mRNA | CTD | PMID:15120968|PMID:15890375 |
Igfbp1 | Mouse | methapyrilene | decreases expression | ISO | RGD:2872 | 6480464 | Methapyrilene results in decreased expression of IGFBP1 mRNA | CTD | PMID:30467583 |
Igfbp1 | Mouse | methylarsonic acid | increases expression | EXP | | 6480464 | monomethylarsonic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15345372 |
Igfbp1 | Mouse | methylmercury(1+) | decreases expression | ISO | RGD:2872 | 6480464 | methylmercury II results in decreased expression of IGFBP1 mRNA | CTD | PMID:17905399 |
Igfbp1 | Mouse | metyrapone | multiple interactions | ISO | RGD:2872 | 6480464 | [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased more ... | CTD | PMID:37088303 |
Igfbp1 | Mouse | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of IGFBP1 mRNA | CTD | PMID:17654400 |
Igfbp1 | Mouse | mifepristone | multiple interactions | ISO | RGD:69038 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGFBP1 protein] | CTD | PMID:26604029 |
Igfbp1 | Mouse | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2872 | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] | CTD | PMID:22129741 |
Igfbp1 | Mouse | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69038 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] | CTD | PMID:26138014 |
Igfbp1 | Mouse | N-nitrosodiethylamine | increases expression | ISO | RGD:69038 | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:21527772 |
Igfbp1 | Mouse | N-nitrosodiethylamine | multiple interactions | ISO | RGD:2872 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA; Acetylcysteine inhibits the reaction more ... | CTD | PMID:22129741 |
Igfbp1 | Mouse | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:12771043|PMID:17942915|PMID:24535843 |
Igfbp1 | Mouse | N-nitrosodiethylamine | increases expression | ISO | RGD:2872 | 6480464 | Diethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:19638242 |
Igfbp1 | Mouse | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA; MET protein inhibits the more ... | CTD | PMID:17942915|PMID:24535843 |
Igfbp1 | Mouse | N-nitrosodimethylamine | increases expression | ISO | RGD:2872 | 6480464 | Dimethylnitrosamine results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375|PMID:25380136 |
Igfbp1 | Mouse | N-nitrosodimethylamine | decreases expression | ISO | RGD:2872 | 6480464 | Dimethylnitrosamine results in decreased expression of IGFBP1 mRNA | CTD | PMID:17072980 |
Igfbp1 | Mouse | N-Nitrosopyrrolidine | increases expression | ISO | RGD:69038 | 6480464 | N-Nitrosopyrrolidine results in increased expression of IGFBP1 mRNA | CTD | PMID:32234424 |
Igfbp1 | Mouse | NAD zwitterion | multiple interactions | ISO | RGD:69038 | 6480464 | NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | NAD zwitterion | increases expression | ISO | RGD:69038 | 6480464 | NAD results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | NAD(+) | increases expression | ISO | RGD:69038 | 6480464 | NAD results in increased expression of IGFBP1 mRNA | CTD | PMID:32781018 |
Igfbp1 | Mouse | NAD(+) | multiple interactions | ISO | RGD:69038 | 6480464 | NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of more ... | CTD | PMID:32781018 |
Igfbp1 | Mouse | nefazodone | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | nevirapine | multiple interactions | EXP | | 6480464 | Nevirapine results in increased expression of and results in increased secretion of IGFBP1 protein | CTD | PMID:38636494 |
Igfbp1 | Mouse | nevirapine | increases expression | EXP | | 6480464 | Nevirapine results in increased expression of IGFBP1 mRNA | CTD | PMID:38636494 |
Igfbp1 | Mouse | nickel dichloride | increases expression | ISO | RGD:69038 | 6480464 | nickel chloride results in increased expression of IGFBP1 mRNA | CTD | PMID:21455298 |
Igfbp1 | Mouse | nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] | CTD | PMID:16917544 |
Igfbp1 | Mouse | nitrofen | increases expression | ISO | RGD:2872 | 6480464 | nitrofen results in increased expression of IGFBP1 mRNA | CTD | PMID:27592368|PMID:33484710 |
Igfbp1 | Mouse | ochratoxin A | decreases expression | ISO | RGD:69038 | 6480464 | ochratoxin A results in decreased expression of IGFBP1 mRNA; ochratoxin A results in decreased expression more ... | CTD | PMID:19287073 |
Igfbp1 | Mouse | ochratoxin A | increases expression | ISO | RGD:2872 | 6480464 | ochratoxin A results in increased expression of IGFBP1 mRNA | CTD | PMID:19717638 |
Igfbp1 | Mouse | okadaic acid | decreases expression | ISO | RGD:69038 | 6480464 | Okadaic Acid results in decreased expression of IGFBP1 mRNA | CTD | PMID:38832940 |
Igfbp1 | Mouse | orphenadrine | affects expression | ISO | RGD:2872 | 6480464 | Orphenadrine affects the expression of IGFBP1 mRNA | CTD | PMID:23665939 |
Igfbp1 | Mouse | oxazepam | increases expression | EXP | | 6480464 | Oxazepam results in increased expression of IGFBP1 mRNA; Oxazepam results in increased expression of IGFBP1 more ... | CTD | PMID:12727805|PMID:15618236 |
Igfbp1 | Mouse | oxycodone | increases expression | ISO | RGD:2872 | 6480464 | Oxycodone results in increased expression of IGFBP1 mRNA | CTD | PMID:23439660 |
Igfbp1 | Mouse | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of IGFBP1 mRNA | CTD | PMID:16183385 |
Igfbp1 | Mouse | ozone | multiple interactions | ISO | RGD:2872 | 6480464 | [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased more ... | CTD | PMID:37088303 |
Igfbp1 | Mouse | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:17585979 |
Igfbp1 | Mouse | paracetamol | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of IGFBP1 mRNA | CTD | PMID:15606129|PMID:17562736 |
Igfbp1 | Mouse | paracetamol | increases expression | ISO | RGD:2872 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:15120968|PMID:17202762|PMID:17522070 |
Igfbp1 | Mouse | paracetamol | increases expression | ISO | RGD:69038 | 6480464 | Acetaminophen results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227|PMID:29067470 |
Igfbp1 | Mouse | paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 |
Igfbp1 | Mouse | paraquat | multiple interactions | ISO | RGD:2872 | 6480464 | Paraquat inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
Igfbp1 | Mouse | perfluorobutanesulfonic acid | increases expression | ISO | RGD:69038 | 6480464 | perfluorobutanesulfonic acid results in increased expression of IGFBP1 protein | CTD | PMID:38758093 |
Igfbp1 | Mouse | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:37995155 |
Igfbp1 | Mouse | perfluorononanoic acid | increases expression | ISO | RGD:69038 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:32588087 |
Igfbp1 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA | CTD | PMID:36331819 |
Igfbp1 | Mouse | perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:69038 | 6480464 | perfluorooctane sulfonic acid affects the expression of IGFBP1 mRNA | CTD | PMID:36864359 |
Igfbp1 | Mouse | perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69038 | 6480464 | perfluorooctane sulfonic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:33772556 |
Igfbp1 | Mouse | perfluorooctanoic acid | decreases expression | ISO | RGD:69038 | 6480464 | perfluorooctanoic acid results in decreased expression of IGFBP1 protein | CTD | PMID:26879310 |
Igfbp1 | Mouse | perfluorooctanoic acid | increases expression | ISO | RGD:69038 | 6480464 | perfluorooctanoic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:33772556 |
Igfbp1 | Mouse | perfluorooctanoic acid | increases expression | ISO | RGD:2872 | 6480464 | perfluorooctanoic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:28511854 |
Igfbp1 | Mouse | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA; NR1I3 protein affects the more ... | CTD | PMID:19482888|PMID:24535843 |
Igfbp1 | Mouse | phenobarbital | affects expression | ISO | RGD:69038 | 6480464 | Phenobarbital affects the expression of IGFBP1 mRNA | CTD | PMID:19084549|PMID:19159669 |
Igfbp1 | Mouse | phenobarbital | increases secretion | ISO | RGD:69038 | 6480464 | Phenobarbital results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
Igfbp1 | Mouse | phenobarbital | increases expression | ISO | RGD:69038 | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
Igfbp1 | Mouse | phenobarbital | increases expression | ISO | RGD:2872 | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
Igfbp1 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of IGFBP1 mRNA | CTD | PMID:19482888 |
Igfbp1 | Mouse | PhIP | decreases expression | ISO | RGD:2872 | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of IGFBP1 mRNA | CTD | PMID:15059925 |
Igfbp1 | Mouse | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA | CTD | PMID:16368122 |
Igfbp1 | Mouse | phorone | affects expression | ISO | RGD:2872 | 6480464 | phorone affects the expression of IGFBP1 mRNA | CTD | PMID:18198479 |
Igfbp1 | Mouse | piperonyl butoxide | increases expression | ISO | RGD:2872 | 6480464 | Piperonyl Butoxide results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
Igfbp1 | Mouse | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 |
Igfbp1 | Mouse | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA; pirinixic acid results in increased expression more ... | CTD | PMID:12727805|PMID:15618236|PMID:18445702|PMID:23811191 |
Igfbp1 | Mouse | pirinixic acid | increases expression | ISO | RGD:2872 | 6480464 | pirinixic acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15890375 |
Igfbp1 | Mouse | potassium bromate | increases expression | ISO | RGD:2872 | 6480464 | potassium bromate results in increased expression of IGFBP1 mRNA | CTD | PMID:23588252 |
Igfbp1 | Mouse | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of IGFBP1 mRNA | CTD | PMID:23608068 |
Igfbp1 | Mouse | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2872 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA | CTD | PMID:19162173 |
Igfbp1 | Mouse | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of IGFBP1 mRNA | CTD | PMID:28903501 |
Igfbp1 | Mouse | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA | CTD | PMID:22698814|PMID:27413110 |
Igfbp1 | Mouse | progesterone | affects expression | ISO | RGD:69038 | 6480464 | Progesterone affects the expression of IGFBP1 mRNA; Progesterone affects the expression of IGFBP1 protein | CTD | PMID:15501902 |
Igfbp1 | Mouse | progesterone | increases expression | ISO | RGD:69038 | 6480464 | Progesterone results in increased expression of IGFBP1 mRNA | CTD | PMID:17404688|PMID:18815356|PMID:20864642|PMID:26604029 |
Igfbp1 | Mouse | progesterone | increases secretion | ISO | RGD:69038 | 6480464 | Progesterone results in increased secretion of IGFBP1 protein | CTD | PMID:26604029 |
Igfbp1 | Mouse | progesterone | multiple interactions | ISO | RGD:69038 | 6480464 | 4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results more ... | CTD | PMID:17404688|PMID:17484513|PMID:20085912|PMID:23275455|PMID:26604029|PMID:32446389 |
Igfbp1 | Mouse | propanal | decreases expression | ISO | RGD:69038 | 6480464 | propionaldehyde results in decreased expression of IGFBP1 mRNA | CTD | PMID:26079696 |
Igfbp1 | Mouse | quercetin | decreases expression | ISO | RGD:69038 | 6480464 | Quercetin results in decreased expression of IGFBP1 mRNA | CTD | PMID:21632981 |
Igfbp1 | Mouse | quinolin-8-ol | increases expression | ISO | RGD:69038 | 6480464 | Oxyquinoline results in increased expression of IGFBP1 mRNA | CTD | PMID:21632981 |
Igfbp1 | Mouse | resveratrol | multiple interactions | ISO | RGD:2872 | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA]; resveratrol inhibits more ... | CTD | PMID:15788402|PMID:16626303 |
Igfbp1 | Mouse | resveratrol | multiple interactions | ISO | RGD:69038 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP1 mRNA | CTD | PMID:23557933 |
Igfbp1 | Mouse | resveratrol | increases expression | ISO | RGD:69038 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:12154049 |
Igfbp1 | Mouse | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] | CTD | PMID:16917544 |
Igfbp1 | Mouse | resveratrol | increases expression | ISO | RGD:2872 | 6480464 | resveratrol results in increased expression of IGFBP1 mRNA | CTD | PMID:16236254 |
Igfbp1 | Mouse | riddelliine | increases expression | ISO | RGD:2872 | 6480464 | riddelliine results in increased expression of IGFBP1 mRNA | CTD | PMID:18047727 |
Igfbp1 | Mouse | rifampicin | multiple interactions | ISO | RGD:69038 | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA | CTD | PMID:21127053 |
Igfbp1 | Mouse | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:2872 | 6480464 | Buthionine Sulfoximine inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] | CTD | PMID:17213664 |
Igfbp1 | Mouse | Salvianolic acid A | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [salvianolic acid A inhibits the reaction [Fatty Acids, Nonesterified results in more ... | CTD | PMID:39047806 |
Igfbp1 | Mouse | silicon dioxide | increases expression | ISO | RGD:69038 | 6480464 | Silicon Dioxide analog results in increased expression of IGFBP1 mRNA | CTD | PMID:25895662 |
Igfbp1 | Mouse | sirolimus | increases expression | ISO | RGD:2872 | 6480464 | Sirolimus results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
Igfbp1 | Mouse | sodium arsenite | multiple interactions | EXP | | 6480464 | [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA; [sodium arsenite co-treated more ... | CTD | PMID:16368122|PMID:19665456 |
Igfbp1 | Mouse | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of IGFBP1 mRNA | CTD | PMID:17350061|PMID:17451858|PMID:33933676 |
Igfbp1 | Mouse | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of IGFBP1 mRNA | CTD | PMID:14691202|PMID:15276417|PMID:17077188 |
Igfbp1 | Mouse | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of IGFBP1 mRNA | CTD | PMID:16507464 |
Igfbp1 | Mouse | sodium dichromate | increases expression | ISO | RGD:2872 | 6480464 | sodium bichromate results in increased expression of IGFBP1 mRNA | CTD | PMID:25993096 |
Igfbp1 | Mouse | sotorasib | multiple interactions | ISO | RGD:69038 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA | CTD | PMID:36139627 |
Igfbp1 | Mouse | starch | multiple interactions | ISO | RGD:2872 | 6480464 | Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of IGFBP1 mRNA] | CTD | PMID:27363782 |
Igfbp1 | Mouse | stavudine | increases expression | ISO | RGD:2872 | 6480464 | Stavudine results in increased expression of IGFBP1 mRNA | CTD | PMID:18299183 |
Igfbp1 | Mouse | streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with [APOE protein affects the susceptibility to Dietary Fats]] affects the expression of more ... | CTD | PMID:39047806 |
Igfbp1 | Mouse | succimer | multiple interactions | ISO | RGD:69038 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA | CTD | PMID:26378955 |
Igfbp1 | Mouse | Sunset Yellow FCF | multiple interactions | ISO | RGD:69038 | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... | CTD | PMID:33819548 |
Igfbp1 | Mouse | tacrolimus hydrate | decreases expression | ISO | RGD:2872 | 6480464 | Tacrolimus results in decreased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
Igfbp1 | Mouse | tacrolimus hydrate | increases expression | ISO | RGD:2872 | 6480464 | Tacrolimus results in increased expression of IGFBP1 mRNA | CTD | PMID:21865292 |
Igfbp1 | Mouse | tamoxifen | multiple interactions | ISO | RGD:69038 | 6480464 | [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein | CTD | PMID:16847815 |
Igfbp1 | Mouse | tamoxifen | increases expression | ISO | RGD:69038 | 6480464 | Tamoxifen results in increased expression of IGFBP1 mRNA | CTD | PMID:27089845 |
Igfbp1 | Mouse | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of IGFBP1 mRNA | CTD | PMID:20937368 |
Igfbp1 | Mouse | tauroursodeoxycholic acid | increases expression | ISO | RGD:2872 | 6480464 | ursodoxicoltaurine results in increased expression of IGFBP1 mRNA | CTD | PMID:15885361 |
Igfbp1 | Mouse | testosterone | multiple interactions | ISO | RGD:69038 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
Igfbp1 | Mouse | testosterone | decreases expression | ISO | RGD:69038 | 6480464 | Testosterone results in decreased expression of IGFBP1 mRNA | CTD | PMID:21592394 |
Igfbp1 | Mouse | tetrachloroethene | increases expression | EXP | | 6480464 | Tetrachloroethylene results in increased expression of IGFBP1 mRNA | CTD | PMID:28973375 |
Igfbp1 | Mouse | tetrachloromethane | affects expression | ISO | RGD:2872 | 6480464 | Carbon Tetrachloride affects the expression of IGFBP1 mRNA | CTD | PMID:15963342 |
Igfbp1 | Mouse | tetrachloromethane | multiple interactions | ISO | RGD:2872 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] | CTD | PMID:31150632 |
Igfbp1 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of IGFBP1 mRNA | CTD | PMID:27339419|PMID:31919559 |
Igfbp1 | Mouse | tetrachloromethane | increases expression | ISO | RGD:2872 | 6480464 | Carbon Tetrachloride results in increased expression of IGFBP1 mRNA | CTD | PMID:15070850|PMID:17522070|PMID:30723492|PMID:31150632 |
Igfbp1 | Mouse | tetracycline | increases expression | ISO | RGD:2872 | 6480464 | Tetracycline results in increased expression of IGFBP1 mRNA | CTD | PMID:17522070 |
Igfbp1 | Mouse | tetracycline | increases expression | ISO | RGD:69038 | 6480464 | Tetracycline results in increased expression of IGFBP1 mRNA | CTD | PMID:27089845 |
Igfbp1 | Mouse | thiabendazole | multiple interactions | ISO | RGD:2872 | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 |
Igfbp1 | Mouse | thiabendazole | increases expression | ISO | RGD:69038 | 6480464 | Thiabendazole results in increased expression of IGFBP1 mRNA | CTD | PMID:39207506 |
Igfbp1 | Mouse | thioacetamide | increases expression | ISO | RGD:69038 | 6480464 | Thioacetamide results in increased expression of IGFBP1 mRNA | CTD | PMID:11793227 |
Igfbp1 | Mouse | thioacetamide | multiple interactions | ISO | RGD:2872 | 6480464 | halofuginone inhibits the reaction [Thioacetamide results in decreased expression of IGFBP1 mRNA] | CTD | PMID:14739098 |
Igfbp1 | Mouse | thioacetamide | decreases expression | ISO | RGD:2872 | 6480464 | Thioacetamide results in decreased expression of IGFBP1 mRNA | CTD | PMID:14739098 |
Igfbp1 | Mouse | thioacetamide | increases expression | ISO | RGD:2872 | 6480464 | Thioacetamide results in increased expression of IGFBP1 mRNA | CTD | PMID:16297948 |
Igfbp1 | Mouse | tianeptine | increases expression | ISO | RGD:69038 | 6480464 | tianeptine results in increased expression of IGFBP1 mRNA | CTD | PMID:27089845 |
Igfbp1 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of IGFBP1 mRNA | CTD | PMID:23557971 |
Igfbp1 | Mouse | tolcapone | increases expression | ISO | RGD:2872 | 6480464 | tolcapone results in increased expression of IGFBP1 mRNA | CTD | PMID:24136188 |
Igfbp1 | Mouse | trametinib | multiple interactions | ISO | RGD:69038 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA | CTD | PMID:36139627 |
Igfbp1 | Mouse | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of IGFBP1 mRNA | CTD | PMID:31939706 |
Igfbp1 | Mouse | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of IGFBP1 mRNA | CTD | PMID:25549359 |
Igfbp1 | Mouse | triclosan | increases expression | ISO | RGD:69038 | 6480464 | Triclosan results in increased expression of IGFBP1 mRNA | CTD | PMID:26604029|PMID:34681664 |
Igfbp1 | Mouse | triclosan | increases secretion | ISO | RGD:69038 | 6480464 | Triclosan results in increased secretion of IGFBP1 protein | CTD | PMID:26604029 |
Igfbp1 | Mouse | triclosan | multiple interactions | ISO | RGD:69038 | 6480464 | [Progesterone co-treated with Triclosan] results in increased expression of IGFBP1 mRNA; Progesterone promotes the reaction more ... | CTD | PMID:26604029 |
Igfbp1 | Mouse | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of IGFBP1 mRNA | CTD | PMID:32835833 |
Igfbp1 | Mouse | Triptolide | decreases expression | ISO | RGD:2872 | 6480464 | triptolide results in decreased expression of IGFBP1 mRNA | CTD | PMID:23639586 |
Igfbp1 | Mouse | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:69038 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of IGFBP1 mRNA | CTD | PMID:29024780 |
Igfbp1 | Mouse | troglitazone | increases expression | ISO | RGD:69038 | 6480464 | troglitazone results in increased expression of IGFBP1 mRNA | CTD | PMID:12659874 |
Igfbp1 | Mouse | troglitazone | decreases expression | ISO | RGD:69038 | 6480464 | troglitazone results in decreased expression of IGFBP1 mRNA | CTD | PMID:25572481 |
Igfbp1 | Mouse | troglitazone | increases secretion | ISO | RGD:69038 | 6480464 | troglitazone results in increased secretion of IGFBP1 protein | CTD | PMID:12659874 |
Igfbp1 | Mouse | trovafloxacin | multiple interactions | EXP | | 6480464 | [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IGFBP1 mRNA | CTD | PMID:18930950 |
Igfbp1 | Mouse | tunicamycin | increases expression | ISO | RGD:69038 | 6480464 | Tunicamycin results in increased expression of IGFBP1 mRNA | CTD | PMID:33545341|PMID:38498338 |
Igfbp1 | Mouse | urethane | increases expression | ISO | RGD:69038 | 6480464 | Urethane results in increased expression of IGFBP1 mRNA | CTD | PMID:28818685 |
Igfbp1 | Mouse | ursodeoxycholic acid | increases expression | ISO | RGD:2872 | 6480464 | Ursodeoxycholic Acid results in increased expression of IGFBP1 mRNA | CTD | PMID:15885361 |
Igfbp1 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of IGFBP1 mRNA | CTD | PMID:17963808 |
Igfbp1 | Mouse | vancomycin | affects expression | ISO | RGD:2872 | 6480464 | Vancomycin affects the expression of IGFBP1 mRNA | CTD | PMID:18289764 |
Igfbp1 | Mouse | vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of IGFBP1 mRNA | CTD | PMID:18930951 |
Igfbp1 | Mouse | vandetanib | increases expression | ISO | RGD:69038 | 6480464 | vandetanib results in increased expression of IGFBP1 mRNA | CTD | PMID:16052530 |
Igfbp1 | Mouse | vemurafenib | multiple interactions | ISO | RGD:69038 | 6480464 | [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of IGFBP1 protein | CTD | PMID:27169980 |
Igfbp1 | Mouse | zinc atom | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 mRNA; Zinc deficiency results in decreased expression more ... | CTD | PMID:12672911|PMID:20404036 |
Igfbp1 | Mouse | zinc(0) | decreases expression | ISO | RGD:2872 | 6480464 | Zinc deficiency results in decreased expression of IGFBP1 mRNA; Zinc deficiency results in decreased expression more ... | CTD | PMID:12672911|PMID:20404036 |